Related Experiment Video
Updated: Jan 10, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Integrating large scale genetic and clinical information to predict cases of heart failure
Kuan-Han H Wu1, Brooke N Wolford2, Jiacong Du3
1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Insights
Integrating genetic and electronic health record risk scores significantly improves early heart failure prediction. This combined approach enhances risk identification years before diagnosis, enabling timely interventions.
Area of Science:
- Genetics and Genomics
- Cardiovascular Disease Epidemiology
- Health Informatics
Background:
- Heart failure (HF) is a leading global cause of mortality.
- Early identification of individuals at risk for HF is crucial for effective intervention.
- Existing prediction models may not fully leverage diverse data sources.
Purpose of the Study:
- To enhance heart failure (HF) prediction accuracy by integrating polygenic risk scores (PRS) from genome-wide association studies (GWAS) and clinical risk scores (ClinRS) derived from electronic health records (EHR).
- To evaluate the performance of combined PRS and ClinRS against individual scores and existing HF risk models.
Main Methods:
- Developed a PRS from a large HF GWAS.
- Created a ClinRS using natural language processing and LASSO regression on EHR data from three Michigan Medicine cohorts.
- Compared the predictive performance of baseline models, PRS, ClinRS, and a combined ClinRS+PRS model using logistic regression.
- Validated models against the Atherosclerosis Risk in Communities (ARIC) HF risk score.
Main Results:
- Both PRS and ClinRS significantly improved HF prediction compared to baseline models, up to eight years pre-diagnosis.
- The combined ClinRS+PRS model enhanced prediction performance up to ten years pre-diagnosis, two years earlier than individual scores.
- ClinRS demonstrated superior performance over the ARIC HF risk score one year prior to diagnosis.
Conclusions:
- Integrating GWAS-derived PRS and EHR-derived ClinRS offers additive predictive power for identifying individuals at risk of heart failure before clinical diagnosis.
- This standardized and scalable risk prediction tool holds potential for facilitating earlier physician interventions and improving patient outcomes.
Background:
Heart failure (HF) is a major global cause of death. Early risk prediction and intervention could mitigate disease progression. We aimed to improve HF prediction by integrating genome-wide association studies (GWAS)- and electronic health records (EHR)-derived risk scores.
Methods:
We previously performed a large HF GWAS within the Global Biobank Meta-analysis Initiative to create a polygenic risk score (PRS). Three Michigan Medicine (MM) cohorts were used to develop the clinical risk score (ClinRS): 1) Primary Care Provider cohort (MM-PCP; N = 61,849), 2) Heart Failure cohort (MM-HF; N = 53,272), and 3) Michigan Genomics Initiative cohort (MM-MGI; N = 60,215). To extract information from high-dimensional EHR data, we leveraged natural language processing to generate 350 latent phenotypes representing EHR codes and used coefficients from LASSO regression on these phenotypes in a training set as weights to calculate ClinRS in a validation set. Using logistic regression, model performances were compared between baseline model and models with risk scores added: 1) PRS, 2) ClinRS, and 3) ClinRS+PRS. We further compared the proposed models with Atherosclerosis Risk in Communities (ARIC) HF risk score.
Results:
PRS and ClinRS each predict HF outcomes significantly better than the baseline model, up to eight years prior to HF diagnosis. Including both PRS and ClinRS further improves prediction performance up to ten years prior to diagnosis, two years earlier than either score alone. Additionally, ClinRS significantly outperforms the ARIC model one year prior.
Conclusions:
We demonstrate the additive power of integrating GWAS- and EHR-derived risk scores to predict HF cases prior to diagnosis. This standardizable and scalable risk predictor may enable physicians to provide earlier interventions to improve patient outcomes.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations